Efficacy of low-dose radiotherapy in painful gonarthritis: experiences from a retrospective East German bicenter study
© Keller et al.; licensee BioMed Central Ltd. 2013
Received: 22 November 2012
Accepted: 20 January 2013
Published: 31 January 2013
To evaluate the efficacy of low-dose radiotherapy in painful gonarthritis.
We assessed the medical records of 1037 patients with painful gonarthritis who had undergone low-dose radiotherapy between 1981 and 2008. The subjective patient perception of the response to irradiation as graded immediately or up to two months after the completion of a radiotherapy series was evaluated and correlated with age, gender, radiological grading and the duration of symptoms before radiotherapy. Moreover, we performed a mail survey to obtain additional long-term follow-up information and received one hundred and six evaluable questionnaires.
We assessed 1659 series of radiotherapy in 1037 patients. In 79.3% of the cases the patients experienced a slight, marked or complete pain relief immediately or up to two months after the completion of radiotherapy. Gender, age and the duration of pain before radiotherapy did not have a significant influence on the response to irradiation. In contrast, severe signs of osteoarthritis were associated with more effective pain relief. In more than 50% of the patients who reported a positive response to irradiation a sustained period of symptomatic improvement was observed.
Our results confirm that low-dose radiotherapy is an effective treatment for painful osteoarthritis of the knee. In contrast to an earlier retrospective study, severe signs of osteoarthritis constituted a positive prognostic factor for the response to irradiation. A randomized trial is urgently required to compare radiotherapy with other treatment modalities.
KeywordsOsteoarthritis Knee Radiotherapy Irradiation X-ray Gonarthritis Gonarthrosis Osteoarthrosis
Painful osteoarthritis of the knee is one of the world’s most common degenerative joint disorders[1, 2]. Its analgetic treatment with low-dose ionizing radiation has a long tradition in Germany[3–5]. Nevertheless, the acceptance of this method, especially abroad, has to be considered low. Accordingly, radiotherapy still has not been included as a therapeutic option in the European League against Rheumatism (EULAR) guidelines and usually represents the “last resort” before surgery. Until recently the pain-relieving effect of radiotherapy in painful gonarthritis was mainly demonstrated by earlier studies, which were highly susceptible to criticism due to methodological weaknesses, outdated radiation techniques and partly low numbers of patients. In 2010 the German Cooperative Group on Radiotherapy for Benign Diseases (GCG-BD) resumed the issue again releasing the results of a large pattern of care study on the role of radiotherapy in painful and refractory gonarthritis which had been conducted in 42 German radiotherapy institutions from 2006 to 2008. High response and low toxicity could be demonstrated in a very large number (n = 5069) of cases. However, one may object that there are methodological problems that are inherent to this kind of survey. The quality of data can be verified only with great difficulty and the information may reflect rough estimates or personal opinions. The purpose of this retrospective bicenter study was to provide evidence that radiotherapy is effective in the treatment of painful gonarthritis and thus can be a reasonable alternative to other therapeutic options. Furthermore we investigated the influence of possible prognostic factors on the pain relieving effect of radiotherapy. We finally performed a systematic literature search and discussed our results in the light of recent releases.
Summary of the fractionation schemes & dose prescriptions
Fractions per week
Single dose (Gy)
Total dose (Gy)
Potential prognostic factors as age, gender, radiological grading and the duration of pain before radiotherapy were correlated with the response to irradiation using the chi square test. Statistical analysis was performed using MS Excel 2007 and SPSS 15.0.
We performed Pubmed and Web of Science search with predefined search terms. The search was limited to English- and German-language articles published since 1980. English key words were: osteoarthritis, knee, radiotherapy, irradiation, x-ray, gonarthritis, gonarthrosis, osteoarthrosis. German key words were: Osteoarthrose (itis), Arthrose (itis), Knie, Röntgenreizbestrahlung, Bestrahlung, Radiotherapie, Gonarthrose (itis). We identified 109 articles and abstracts by the search terms. After title and abstract review a preclinical and four clinical articles[5, 10–12] about radiotherapy in painful gonarthritis were eligible. In addition, we performed hand search following the references from selected articles.
This retrospective study is in compliance with the Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Subjects – and its amendments.
≤ 60 years
> 60 years
Duration of pain
< 1 year
1 – 3 years
> 3 years
Response to treatment as recorded immediately or up to two months after radiotherapy
Response to treatment as recorded by the additional mail survey
Best response to radiotherapy
Similar to the previous studies identified by our literature search this large retrospective analysis demonstrates the good analgetic effect of radiotherapy in painful osteoarthritis of the knee. In 80% of the cases the irradiated patients reported a positive response to treatment immediately or up to two months after the completion of the respective series. However, the proportion of very good responders, i.e., patients who were free of pain or in whom the symptoms had markedly improved after a series of radiotherapy, was low in comparison to the other series (Additional file1: Table S1). A possible explanation for that phenomenon could be that, for practical reasons, the response to treatment had been evaluated more likely immediately rather than several weeks after the completion of radiotherapy.
Point of time of the best response to radiotherapy
The assessment of the treatment effect should be performed immediately and a few weeks after the completion of radiotherapy, since in a high percentage of cases outcome apparently improves over time. Several analyses demonstrate that approximately ten percent of the patients are free of symptoms or feel significant pain relief directly after the completion of radiotherapy[10, 13]. In the cohort assessed by Keinert et al. the proportion of patients with complete resolution of symptoms increased from 8 to 38 percent in the following six weeks. In a cohort of 21 patients assessed by Sautter-Bihl et al. the final treatment success occurred in 10% during, in 14% immediately after and in 76% within six weeks after radiotherapy. Accordingly Ruppert et al. investigated a cohort of 73 patients with painful osteoarthritis affecting different joints and reported a delay of ten weeks between the start of radiotherapy and by pain reduction in 47% of the patients who responded to treatment.
Duration of the analgetic effect
57% of the responders in our cohort experienced notable pain-relief for more than a year (Figure 8). In contrast, Mücke et al. reported a median estimate for the share of patients who experienced pain reduction for at least 12 months of only 40%. In the cohort of patients assessed by Sautter-Bihl et al. the pain-relieving effect of radiotherapy lasted longer than 12 months in 67% of the cases. In the analysis performed by Keinert et al. the share of the responders who suffered a recurrence ranged between 30% (patients with marked pain-relief) and 50% (patients who were free of pain after radiotherapy). This observation was confirmed by Keilholz at al. who found a relapse rate of 33% in a cohort of 30 responders. The analgetic potential of radiotherapy in painful osteoarthritis of the knee seems to be comparable to that in other big joints.
Gender and age
Neither gender (Figure 2) nor age (Figure 3) had a significant influence on the pain-relieving effect in this retrospective study. In contrast in the analysis performed by Keilholz et al. the patients < 80 years tended to have a more favorable treatment response (univariate analysis, p = 0.08). However this trend could not be confirmed in multivariate analysis. In the study of Glatzel et al. age (≤ 60 years versus > 60 years) did not influence outcome whereas best results with a clear analgesic effect were reached in males (29/50, 58% versus femals: 39/135, 29%). The factor gender had an independent prognostic value (p < 0.01).
The impact of the radiological severity of osteoarthritis on the response to radiotherapy remains controversial. In this study in 84.9% of the cases with severe signs of osteoarthritis the first irradiation series led to slight or marked pain-relief. In the cases with minimal/ moderate signs of osteoarthritis this result was only achieved in 77.2%/ 78.3%. The difference proved to be significant. In contrast, in the analysis released by Keilholz et al. the patients with severe radiological signs of osteoarthritis tended to respond worse to radiotherapy in univariate analysis.
Duration of symptoms
Some authors stated that the results of treatment were dependent on the duration of symptoms before the start of radiotherapy. In the cohort of Keinert et al. 48% of the patients with a short duration of symptoms (<1 year) were pain-free after irradiation. In patients with a longer duration of symptoms (>1 year) this result was only achieved in 25%. Keinert et al. derived from their observations the demand to use irradiation, contrary to the usual practice, as early treatment option. This demand was supported by Keilholz et al. and Glatzel et al. who demonstrated that a short duration of pain symptoms before the start of radiotherapy (≤ 2 years and ≤1 year respectively) was an independent positive prognostic factor for the success of pain-relieving radiotherapeutic treatment in multivariate analysis (p < 0.05)[11, 14]. In contrast, in our cohort there was no significant difference in radiation-induced pain relief between the patients who reported a history of pain of less than a year, 1 to 3 years or more than 3 years prior to radiotherapy.
RT–technique and dosage
The optimal radiotherapy technique and dosage are currently unknown. Frequently two opposed irradiation fields are used and the reference point of the dose is placed in the center of the joint. However, assuming a typical knee diameter of 10 cm, the clinical relevance of this approach may be questioned, as the respective dose distributions within the knee joint will diverge only marginally if the reference point is shifted to the skin surface (Additional file1: Figure S1). Although in our cohort the use of alternating single fields was associated with a better response to treatment (data not shown), we are reluctant to derive radiotherapy planning recommendations from those findings as our results may be biased by the variety of additional factors influencing the dose distribution within the knee joint (i.g. acceleration voltage, thickness of the filter, focus-skin distance, field size, diameter of the knee) by different dose prescriptions and fractionation schemes (Table 1) or other not treatment related factors.
According to Mücke et al. most institutions in Germany irradiate with a median single dose of 1 Gy twice (40%) or three times (51%) a week and a median total dose of 6 Gy.
In our institutions the majority of patients received single doses of 1 Gy (83.7%). A total doses of 6 Gy was only administered in 7.4% of the cases. Most patients (54.2%) received a total dose of 4 Gy. About two thirds of our patients underwent irradiation once and one third twice a week. A limitation of our analysis is that the influence of different dose-fractionation schedules on treatment response in painful gonarthritis could not be assessed. Niewald et al. conducted a randomized trial of radiation therapy for painful heel spur, comparing a standard dose with a very low dose. Sixty-six patients were randomized to receive radiation therapy either with a total dose of 6.0 Gy applied in 6 fractions of 1.0 Gy twice weekly (standard dose) or with a total dose of 0.6 Gy applied in 6 fractions of 0.1 Gy twice weekly (low dose). After 3 months the results in the standard arm were significantly superior compared with those in the low-dose arm. The accrual of patients was stopped at this point. Heyd et al. evaluated the efficacy of two different dose-fractionation schedules for radiation therapy (RT) in patients with painful heel spur. 130 patients were randomized into two groups: the low-dose (LD) group (n = 65 heels) received a total dose of 3.0 Gy given in two weekly fractions of 0.5 Gy; in the high-dose (HD) group (n = 65 heels), two weekly fractions of 1.0 Gy were applied over 3 weeks (total dose 6.0 Gy). No statistically significant difference of response to RT between both groups was observed. These results are in accordance with the findings of Ott et al. who evaluated the efficacy of two different dose-fractionation schedules for radiotherapy of patients with painful elbow syndrome. One RT course consisted of 6 single fractions/ 3 weeks. Patients were randomly assigned to receive either single doses of 0.5 or 1.0 Gy. Endpoint was pain reduction. No statistically significant differences between the two single dose trial arms for early (p = 0.103) and delayed response (p = 0.246) were found. Liebmann et al. explored the efficacy of low-dose radiotherapy in adjuvant induced gonarthritis in rats using different fractionation schemes to specify a possible dose and fractionation dependence. Based on the experimental data they recommended two series of 5 × 0.5 Gy with an early treatment onset and repetition in interval during the florid phase of arthritis as most effective radiotherapy regimen to prevent a full-blown arthritic reaction.
Mechanism of action
Pathophysiology of osteoarthritisis has not yet been understood completely. However, arthrosis, i.e. the degeneration of articular cartilage, leads to an inflammatory reaction in the synovial membrane which again aggravates arthrosis. Several authors showed in animal models that low-dose radiotherapy attenuates the arthritic response by anti-inflammatory effects and decreases its clinical symptoms[9, 18, 20].
Risk of somatic damage and malignant transformation
The risks of radiation exposure always have to be weighed against the therapeutic benefit. Somatic damage is not expected at the given low doses. Moreover since most patients are seniors damage to the genetic material plays only a minor role. According to Jansen et al. the average attributable lifetime risk for an induced fatal tumor for a 25/50/75-year-old woman is 4/1/0.5 ‰ for a double series treatment with a target dose of 12 Gy. For a single series these values are 2.0, 0.7 and 0.3 respectively. Despite these considerations compliance with all health and safety rules remains a matter of course for each radiotherapist.
In accordance with previous retrospective analyses, especially the large pattern of care study of the German Cooperative Group on Radiotherapy for Benign Diseases, our results confirm that low-dose radiotherapy is an effective treatment for painful osteoarthritis of the knee. The influence of radiological severity on treatment outcome remains unclear. In contrast to an earlier retrospective study we identified severe signs of osteoarthritis as positive prognostic factor for treatment response. A randomized trial is urgently required to compare radiotherapy with other therapy methods.
The authors wish to acknowledge Ms. Christiane Hofmann for her meticulous literature search.
- Felson DT: Osteoarthritis. Rheum Dis Clin North Am 1990, 16: 499-512.PubMedGoogle Scholar
- Engelhardt M: Epidemiologie der arthrose in westeuropa. Dtsch Z Sportmed 2003, 54: 171-175.Google Scholar
- Fried G: Die röntgentherapie der arthritis. Strahlentherapie 1934, 49: 634-675.Google Scholar
- Toschke G: Zur röntgenbehandlung von gelenkerkrankungen. Strahlentherapie 1941, 70: 443-456.Google Scholar
- Mücke R, Seegenschmiedt MH, Heyd R, Schafer U, Prott FJ, Glatzel M, Micke O: Radiotherapy in painful gonarthrosis. Results of a national patterns-of-care study. Strahlenther Onkol 2010, 186: 7-17. 10.1007/s00066-009-1995-7View ArticlePubMedGoogle Scholar
- Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, Gunther K, Hauselmann H, Herrero-Beaumont G, Kaklamanis P: EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT). Ann Rheum Dis 2003, 62: 1145-1155. 10.1136/ard.2003.011742View ArticlePubMedPubMed CentralGoogle Scholar
- Kellgren JH, Lawrence JS: Osteo-arthrosis and disk degeneration in an urban population. Ann Rheum Dis 1958, 17: 388-397. 10.1136/ard.17.4.388View ArticlePubMedPubMed CentralGoogle Scholar
- Von Pannewitz G (Ed): Roentgen therapy for deforming arthritis. Leipzig: Thieme; 1933.Google Scholar
- Fischer U, Kamprad F, Koch F, Ludewig E, Melzer R, Hildebrandt G: The effects of low-dose Co-60 irradiation on the course of aseptic arthritis in a rabbit knee joint. Strahlenther Onkol 1998, 174: 633-639. 10.1007/BF03038512View ArticlePubMedGoogle Scholar
- Keinert KSU, Schumann E: Ergebnisse der strahlentherapie der arthrosis deformans des kniegelenks. Dt Gesundh-Wesen 1982, 10: 445-447.Google Scholar
- Keilholz L, Seegenschmiedt H, Sauer R: Radiotherapy for painful degenerative joint disorders. Indications, technique and clinical results. Strahlenther Onkol 1998, 174: 243-250. 10.1007/BF03038716View ArticlePubMedGoogle Scholar
- Ruppert R, Seegenschmiedt MH, Sauer R: Radiotherapy of osteoarthritis. Indication, technique and clinical results. Orthopade 2004, 33: 56-62. 10.1007/s00132-003-0568-1View ArticlePubMedGoogle Scholar
- Sautter-Bihl ML, Liebermeister E, Scheurig H, Heinze HG: Analgetic irradiation of degenerative-inflammatory skeletal diseases. Benefits and risks. Dtsch Med Wochenschr 1993, 118: 493-498. 10.1055/s-2008-1059354View ArticlePubMedGoogle Scholar
- Glatzel MF D, Bäsecke S, Krauß A: Prognostic factors of success of analgesic radiotherapy for gonarthrosis. Strahlenther Onkol 2004,180(Sondernr 1):6.Google Scholar
- Niewald M, Seegenschmiedt MH, Micke O, Graeber S, Muecke R, Schaefer V, Scheid C, Fleckenstein J, Licht N, Ruebe C: Randomized, multicenter trial on the effect of radiation therapy on plantar fasciitis (painful heel spur) comparing a standard dose with a very low dose: mature results after 12 months‘ follow-up. Int J Radiat Oncol Biol Phys 2012, 84: e455-462. 10.1016/j.ijrobp.2012.06.022View ArticlePubMedGoogle Scholar
- Heyd R, Tselis N, Ackermann H, Roddiger SJ, Zamboglou N: Radiation therapy for painful heel spurs: results of a prospective randomized study. Strahlenther Onkol 2007, 183: 3-9.View ArticlePubMedGoogle Scholar
- Ott OJ, Hertel S, Gaipl US, Frey B, Schmidt M, Fietkau R: Benign painful elbow syndrome: first results of a single center prospective randomized radiotherapy dose optimization trial. Strahlenther Onkol 2012, 188: 873-877. 10.1007/s00066-012-0179-zView ArticlePubMedGoogle Scholar
- Liebmann A, Hindemith M, Jahns J, Madaj-Sterba P, Weisheit S, Kamprad F, Hildebrandt G: Low-dose X-irradiation of adjuvant-induced arthritis in rats. Efficacy of different fractionation schedules. Strahlenther Onkol 2004, 180: 165-172. 10.1007/s00066-004-1197-2View ArticlePubMedGoogle Scholar
- Trott KR, Parker R, Seed MP: The effect of x-rays on experimental arthritis in the rat. Strahlenther Onkol 1995, 171: 534-538.PubMedGoogle Scholar
- Hildebrandt G, Jahns J, Hindemith M, Spranger S, Sack U, Kinne RW, Madaj-Sterba P, Wolf U, Kamprad F: Effects of low dose radiation therapy on adjuvant induced arthritis in rats. Int J Radiat Biol 2000, 76: 1143-1153. 10.1080/09553000050111613View ArticlePubMedGoogle Scholar
- Jansen JT, Broerse JJ, Zoetelief J, Klein C, Seegenschmiedt HM: Estimation of the carcinogenic risk of radiotherapy of benign diseases from shoulder to heel. Radiother Oncol 2005, 76: 270-277. 10.1016/j.radonc.2005.06.034View ArticlePubMedGoogle Scholar
- Von Pannewitz G: Röntgentherapie der arthrosis deformans. Strahlentherapie 1953, 92: 375-382.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.